hypericum perforatum extract

Deprivita is a phytotherapeutic antidepressant developed and marketed by Permamed. It contains a quantified dry ethanolic extract of St. John's wort (*Hypericum perforatum*), standardized to hypericin. Deprivita is approved in Switzerland for the treatment of mild to moderate depressive episodes. The therapeutic effects of St. John's wort extract are primarily attributed to active constituents such as hyperforin and hypericin, which act by inhibiting the synaptosomal reuptake of key neurotransmitters, including serotonin, norepinephrine, and dopamine, thereby elevating their levels in the synaptic cleft.

Brand names

Deprivita

Other names

Hyperici herbae extractum ethanolicum siccumSt. John's wort extract